Class II · Moderate risk
Sermorelin/GHRP-2 9 mg/6 mg vials
Lack of Sterility Assurance.
Is Sermorelin recalled?
Yes — there is an active recall. 13 ongoing FDA recalls mention Sermorelin (92 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Sermorelin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Sermorelin recalls on record
none so far in 2026; 92 on record, newest first
Class II · Moderate risk
Sermorelin/GHRP-2 9 mg/9 mg vials Pharm D. Solutions 1304 South Loop West
Lack of Sterility Assurance.
Class II · Moderate risk
Sermorelin/Ipamorelin 18 mg/15 mg
Lack of Sterility Assurance.
Class II · Moderate risk
Sermorelin 0.4 mg/0.5 mL
Lack of sterility assurance.
Class II · Moderate risk
Sermorelin 0.3 mg/0.5 mL
Lack of sterility assurance.
Class II · Moderate risk
Sermorelin
Lack of sterility assurance.
Class II · Moderate risk
Ipamorelin+Sermorelin
Lack of sterility assurance.
Class II · Moderate risk
Sermorelin/GHRP2/GHRP6 6mg/3mg/3mg injection
Lack of sterility assurance.
Class II · Moderate risk
Sermorelin/GHRP2/GHRP6
Lack of sterility assurance.
Class II · Moderate risk
Sermorelin 9 mg injection
Lack of sterility assurance.
Class II · Moderate risk
Sermorelin Theanine/GHRP2
Lack of sterility assurance.
Class II · Moderate risk
Sermorelin/GHRP-2/Theanine/Mannitol 15 mg/6 mg/75 mg/300 mg Powder
Lack of Assurance of Sterility
Class II · Moderate risk
Sermorelin/GHRP-2/GHRP-6 Mannitol 9 mg/9 mg/9 mg/300 mg Powder
Lack of Assurance of Sterility
Class II · Moderate risk
Sermorelin/GHRP-2 9 mg/9 mg Powder
Lack of Assurance of Sterility
Class II · Moderate risk
Sermorelin/GHRP-2 9 mg-6 mg Powder
Lack of Assurance of Sterility
Class II · Moderate risk
Sermorelin/GHRP-2 18 mg/6 mg powder
Lack of Assurance of Sterility
Class II · Moderate risk
Sermorelin/GHRP-2 6 mg/6 mg Powder
Lack of Assurance of Sterility
Class II · Moderate risk
Sermorelin/Ipamorelin 18 mg/15 mg Powder
Lack of Assurance of Sterility
Class II · Moderate risk
Sermorelin Acetate
Stability Data Does Not Support Expiry: Stability data from manufacturer does not support expiration dates listed.
Class II · Moderate risk
Sermorelin Acetate 3 mg/ GHRP6 3 mg
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk
Sermorelin
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk
Sermorelin
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk
Sermorelin 500 mcg Orally Disintegrating Tablets
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk
Sermorelin GT
Lack of Assurance of Sterility
Class II · Moderate risk
Sermorelin Forte Plus 27 mg
Lack of Assurance of Sterility
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.